Drug candidate
Frequency Percent of responses Percent of cases
Meplazumab
1 0.44 0.81
Leflumide
1 0.44 0.81
Camrelizumab
1 0.44 0.81
Ulinastatin
1 0.44 0.81
Bevacizumab
2 0.88 1.61
Thalidomide
2 0.88 1.61
Suramin
1 0.44 0.81
Enoxaparin
1 0.44 0.81
Vitamin C
1 0.44 0.81
Tetrandine
1 0.44 0.81
Sildenafil
1 0.44 0.81
Heparin
1 0.44 0.81
Losartan
1 0.44 0.81